medac GmbH
Reiner Ahrendt has extensive work experience in the field of product management, sales, and research. Reiner started their career in 2002 as a student assistant at MPI-CBG, where they were involved in breeding and maintaining fish stocks and routine lab work. In 2003, they interned at Mote Marine Laboratory. Reiner then worked as a research assistant at BIOTEC, TU-Dresden from 2006 to 2011. Reiner gained further research experience as a postdoc at CRTD from 2011 to 2012. In 2013, they joined Biotype Diagnostic GmbH, initially as a scientist and later as a sales and product manager. Reiner continued their product management career at medac GmbH, starting in 2017 as a product manager and currently holding the position of Head of Product Management Diagnostics.
Reiner Ahrendt pursued their education in the field of biology. From the year 2000 to 2005, they attended TU-Dresden where they obtained a degree in Molecular Biology, specifically a Diplom Biologe (Dipl. Biol.). Following this, Reiner Ahrendt continued their studies at TU-Dresden from 2006 to 2011, earning a Dr. rer. nat degree in Biology.
medac GmbH
We are a privately held, medium-sized global pharmaceutical and diagnostics company based in Germany. For more than 50 years we have been committed to high quality products, reliable supply and individual customer services. Today, over 2.000 medac employees worldwide are working together to supply more than 90 countries with our products. Since our foundation we have been specialising in the treatment of oncological, haematological, urological, and autoimmune diseases. Today, we are a leading specialist supplier in oncology and rheumatology. We combine the innovative power of a researching pharmaceutical company with the efficiency of a generics manufacturer and offer both therapeutics and diagnostics. Always putting the needs of patients and healthcare professionals first, we are committed to the refinement of established and the development of new products with additional benefits for patients in specific niche indications with high therapeutic needs.